Hafizi, M., Kalanaky, S., moaiery, H., Khayamzadeh, M., Noorian, S., Kaveh, V., . . . Akbari, M. E. (2019). A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients. J Nanobiotechnology.
Chicago Style CitationHafizi, Maryam, et al. "A Randomized, Double-blind, Placebo-controlled Investigation of BCc1 Nanomedicine Effect On Survival and Quality of Life in Metastatic and Non-metastatic Gastric Cancer Patients." J Nanobiotechnology 2019.
Cita MLAHafizi, Maryam, et al. "A Randomized, Double-blind, Placebo-controlled Investigation of BCc1 Nanomedicine Effect On Survival and Quality of Life in Metastatic and Non-metastatic Gastric Cancer Patients." J Nanobiotechnology 2019.